Pfizer Inc (NYSE:PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ:MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic thanks to mRNA technology. Now, Moderna and Pfizer embarked on a journey to treat cancer with mRNA science. By using mRNA-based next-generation CRC screening tests, a much smaller and less known pharma player, Mainz Biomed N.V. (NASDAQ:MYNZ), is already redefining standards in early cancer detection with its flagship colorectal cancer test ColoAlert, while also tackling cancer prevention.

Moderna...